Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Dr. Dey’s major focus is to facilitate the development of markers and validation of innovative in vitro diagnostics to improve clinical outcomes for cancer patients. Her current role in Diagnostics Evaluation Branch is to foster research into in vitro diagnostics as prognostic markers to improve tumor classification and predictive markers to improve response to therapy. She is also responsible for the scientific oversight of a portfolio of investigator-initiated research grants. She is involved in review of the correlative science aspects of protocols for NCI’s clinical trials program. She oversees and manages cooperative agreement grants for the Cancer Diagnosis Program on Assay Validation of High-Quality Markers for Clinical Studies in Cancer. Dr. Dey earned a doctorate in Biochemistry and then completed post-doctoral research experience at the NCI's Lab of Pathology. There she developed high-throughput molecular techniques to analyze human tissue samples. Dr. Dey joined Cancer Diagnosis Program in 2016 and is an experienced scientific program officer who has supported project management offices in both the DoD and NIH spaces.

  • Updated:
Email